AccessToTreatment.org represents the cooperative effort of five companies: Boehringer Ingelheim International GmbH, Novartis Pharmaceuticals, and Pfizer. The platform was designed and is administered by Axios International, specialists of chronic care systems in developing countries.

Our goal is for institutions and their patients in Least Developed Countries to access the medical products provided under this cooperation.
AccessToTreatment.org currently provides four donation (products are free) and two access (products are sold at no-profit) programs.

"435 healthcare institutions in 93 countries participate. These institutions include governments, non-governmental organizations, faith-based organizations, and international agencies. More than 3 million patients have benefited from access since the year 2000".

We are actively recruiting additional manufacturers and institutions.

Role of Axios International

Axios International works with participating healthcare institutions and manufacturers, to ensure the proper match between products and institutions, analyzing supply and demand, ensuring the respect of pharmaceutical requirements, and the communication of necessary data among partners via a web-based network.

Axios assists applicant institutions by engaging in dialogue to understand the scope of their programs and needs. This includes technical assistance regarding forecasting, procurement, and logistics.

Axios ensures that healthcare institutions benefiting from the discounted prices or donations meet the technical standards required for proper utilization of the drugs and tests.

Axios assists participating manufacturers through the above quality control assurance and by the sharing of information, experience, and the vision of Access To Treatment in developing countries.

.